Soligenix

Youtube Subscribe

Open: 0.71 Close: 0.72 Change: 0.01

Can you guess what an AI found about Soligenix.

This document will help you to evaluate Soligenix without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Soligenix are: receive, EC, approval, Pfizers, colitis, Soligenix, stock, and the …

Concept Map

Semantic Network

Stock Summary

Nano-cap biotech Soligenix gained over 200% on Thursday. Company is a biopharmaceutical company that is publicly traded on the NASDAQ stock exchange under the ticker symbol SNGX. Company focuses on developing treatments for.

Today's Summary

Soligenix stock performed -91.78% worse in the last year and -90.20% worse than Bitcoin. The price of SNGX stock is expected to increase by 678,150.

Today's News

Pfizers VELSIPITY receives EC approval for ulcerative colitis INV-347 by Inversago Pharma for Obesity: Likelihood of Approval. Pfizers receives EC. approval for. ulcerate colitis. Inv-347. Pfizer receives EC. rivax by soligenix for poisoning: likelihood of approval. Soligenix stock performed -91.78% worse in the last year and -90.20% worse than Bitcoin. The price of SNGX stock is expected to increase by 678,150.91%. Soligenix, Inc. (Nasdaq: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company announced today a publication describing the preclinical efficacy of a novel, single-vial, bivalent vaccine.

Stock Profile

" Soligenix shares rise on receiving fda ind clearance for phase 2 clinical trial of dusquetide. The companys SGX945 Phase 2 pilot trial in aphthous ulcers of Behçets disease. Nano-cap biotech Soligenix ( NASDAQ: SNGX) gained over 200% on Thursday after announcing that the U.S. government has approved HyBryte™ for the treatment of cutaneous T-cell lymphoma. Soligenix has a variety of products in its pipeline, including its heat-stable ricin toxin vaccine, RiVax®. The cost of development and manufacturing for its flagship products is estimated to be in the range of $10 million to $20 million. Soligenix, Inc. performed a 1 for 15 Reverse Split. The company is a biopharmaceutical company that is publicly traded on the NASDAQ stock exchange under the ticker symbol SNGX The company focuses on developing treatments for rare diseases with unmet medical needs. FDA has cleared Soligenix Incs (SNGX) Investigational New Drug (IND) application for a Phase 2a clinical trial for SGX945 (dusquetide) for aphthous ulcers in Behçets disease. Soligenix: Witnessed a record-breaking daily growth of 332% of the 65-Day Volume Moving Average on August 15, 2023. Emerged as a top weekly gainer for penny stocks with a remarkable +16.01% rise. Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçets Disease. Company is focused on developing and commercializing products to treat rare diseases where there is an unmet need."

Keywords

The game is changing. There is a new strategy to evaluate Soligenix fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Soligenix are: receive, EC, approval, Pfizers, colitis, Soligenix, stock, and the most common words in the summary are: soligenix, stock, inc, price, sngx, therapeutic, prediction, . One of the sentences in the summary was: Soligenix stock performed -91.78% worse in the last year and -90.20% worse than Bitcoin. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #soligenix #stock #inc #price #sngx #therapeutic #prediction.

Read more →

Youtube Subscribe

---